Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-18

FDA Approved: MODAFINIL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for modafinil from Rising Pharma Holdings, Inc., resulting in a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modafinil (modafinil)

Snippet

SUPPL AP for MODAFINIL (MODAFINIL)